ProShare Advisors’s Radius Health, Inc. RDUS Stock Holding History

ProShare Advisors’s Portfolio RDUS Stock Details RDUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,682	Closed	-$121K	–	2257
2022 Q1	$121K	Sell	13,682 -3,211	-19%	-$24.3K	﹤0.01%	1996
2021 Q4	$116K	Buy	16,893 +797	+5%	+$11.7K	﹤0.01%	2178
2021 Q3	$200K	Sell	16,096 -4,536	-22%	-$65.4K	﹤0.01%	1797
2021 Q2	$376K	Buy	20,632 +1,992	+11%	+$39.6K	﹤0.01%	1739
2021 Q1	$389K	Buy	18,640 +1,389	+8%	+$29.3K	﹤0.01%	1627
2020 Q4	$308K	Buy	17,251 +4,190	+32%	+$62.9K	﹤0.01%	1594
2020 Q3	$148K	Sell	13,061 -528	-4%	-$6.53K	﹤0.01%	1475
2020 Q2	$185K	Buy	+13,589	New	+$187K	﹤0.01%	1479
2020 Q1	–	Sell	-16,094	Closed	-$324K	–	1691
2019 Q4	$324K	Sell	16,094 -1,523	-9%	-$37K	﹤0.01%	1292
2019 Q3	$454K	Sell	17,617 -130	-0.7%	-$3.19K	﹤0.01%	1013
2019 Q2	$432K	Sell	17,747 -2,196	-11%	-$48K	﹤0.01%	1074
2019 Q1	$398K	Buy	19,943 +254	+1%	+$4.63K	﹤0.01%	1124
2018 Q4	$325K	Sell	19,689 -3,807	-16%	-$64.1K	﹤0.01%	1110
2018 Q3	$418K	Sell	23,496 -1,925	-8%	-$43.6K	﹤0.01%	1195
2018 Q2	$749K	Sell	25,421 -1,130	-4%	-$35.7K	0.01%	944
2018 Q1	$954K	Sell	26,551 -4,247	-14%	-$153K	0.01%	841
2017 Q4	$978K	Buy	30,798 +2,794	+10%	+$87.7K	0.01%	848
2017 Q3	$1.08M	Buy	28,004 +1,666	+6%	+$65.4K	0.01%	713
2017 Q2	$1.19M	Sell	26,338 -1,133	-4%	-$43.3K	0.01%	687
2017 Q1	$1.06M	Sell	27,471 -6,611	-19%	-$277K	0.01%	730
2016 Q4	$1.3M	Buy	34,082 +2,699	+9%	+$128K	0.01%	671
2016 Q3	$1.7M	Sell	31,383 -5,640	-15%	-$287K	0.02%	533
2016 Q2	$1.36M	Buy	37,023 +402	+1%	+$14.2K	0.02%	629
2016 Q1	$1.15M	Sell	36,621 -3,974	-10%	-$137K	0.02%	661
2015 Q4	$2.5M	Buy	40,595 +3,574	+10%	+$226K	0.03%	439
2015 Q3	$2.57M	Buy	37,021 +3,055	+9%	+$212K	0.04%	407
2015 Q2	$2.3M	Buy	33,966 +2,511	+8%	+$117K	0.03%	467
2015 Q1	$1.29M	Buy	31,455 +7,989	+34%	+$359K	0.02%	723
2014 Q4	$913K	Buy	+23,466	New	+$556K	0.01%	904

Other funds holding RDUS

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

ProShare Advisors's RDUS Position: Q2 2022 in Review

ProShare Advisors sold out of Radius Health, Inc. (RDUS) in Q2 2022, closing a stake of 13,682 shares — an estimated $121K sold.

ProShare Advisors first reported a position in RDUS in Q4 2014 and held it in 29 quarters. The position peaked at $2.57M in Q3 2015. 123 funds tracked by Wall St. Rank hold RDUS as of Q2 2022.

ProShare Advisors reported no remaining Radius Health, Inc. position as of Q2 2022 after selling out during the quarter.
ProShare Advisors sold 13,682 Radius Health, Inc. shares in Q2 2022, an estimated $121K.
ProShare Advisors first reported a position in Radius Health, Inc. in Q4 2014 and held it in 29 quarters.
ProShare Advisors's Radius Health, Inc. position peaked at $2.57M in Q3 2015.
123 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q2 2022.

Based on ProShare Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.